WO2007026037A3 - Mezcla de aminoácidos tipo micosporina (asterine 330 + palitina) como antioxidante - Google Patents

Mezcla de aminoácidos tipo micosporina (asterine 330 + palitina) como antioxidante Download PDF

Info

Publication number
WO2007026037A3
WO2007026037A3 PCT/ES2006/000491 ES2006000491W WO2007026037A3 WO 2007026037 A3 WO2007026037 A3 WO 2007026037A3 ES 2006000491 W ES2006000491 W ES 2006000491W WO 2007026037 A3 WO2007026037 A3 WO 2007026037A3
Authority
WO
WIPO (PCT)
Prior art keywords
palythine
asterin
mycosporin
amino acids
antioxidant
Prior art date
Application number
PCT/ES2006/000491
Other languages
English (en)
French (fr)
Other versions
WO2007026037A2 (es
Inventor
La Coba Luque Francisca De
Arjona Jose Aguilera
Figueroa Felix Lopez
Original Assignee
Univ Malaga
La Coba Luque Francisca De
Arjona Jose Aguilera
Figueroa Felix Lopez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Malaga, La Coba Luque Francisca De, Arjona Jose Aguilera, Figueroa Felix Lopez filed Critical Univ Malaga
Publication of WO2007026037A2 publication Critical patent/WO2007026037A2/es
Publication of WO2007026037A3 publication Critical patent/WO2007026037A3/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Mezcla de aminoácidos tipo micosporina (asterine 330 + palythine) como antioxidante. La presente invención se encuadra en el sector biotecnológico y describe el potencial uso como sustancia antioxidante de un extracto purificado de aminoácidos tipo micosporina (MAA), concretamente de asterine 330 + palythine aislado del alga roja Gelidium sesquipedale, además de su posible aplicación en preparados farmacéuticos, nutraceúticos, o alimentos funcionales, entre otros, para la prevención de estrés oxidativo.
PCT/ES2006/000491 2005-08-31 2006-08-28 Mezcla de aminoácidos tipo micosporina (asterine 330 + palitina) como antioxidante WO2007026037A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200502158 2005-08-31
ES200502158A ES2303412B1 (es) 2005-08-31 2005-08-31 Uso de una mezcla purificada de aminoaciods tipo micosporina (asterina 330 + palitina) en productos para prevencion de procesos cancerigenos.

Publications (2)

Publication Number Publication Date
WO2007026037A2 WO2007026037A2 (es) 2007-03-08
WO2007026037A3 true WO2007026037A3 (es) 2007-05-18

Family

ID=37809231

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2006/000491 WO2007026037A2 (es) 2005-08-31 2006-08-28 Mezcla de aminoácidos tipo micosporina (asterine 330 + palitina) como antioxidante

Country Status (2)

Country Link
ES (6) ES2303488B1 (es)
WO (1) WO2007026037A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3025426B1 (fr) * 2014-09-09 2016-11-11 Les Laboratoires De Biarritz Extrait d'algue rouge particulier et son utilisation pour le traitement de la peau

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024369A1 (en) * 1998-10-23 2000-05-04 Nouvab Inc Solar radiation protection composition
WO2002039974A1 (en) * 2000-11-17 2002-05-23 Natural Environment Research Council Personal care compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655268B1 (fr) * 1989-12-06 1994-10-14 Secma Utilisation d'extraits d'algues pour la preparation de compositions pharmaceutiques, cosmetiques, alimentaires ou a usage agricole.
FR2803201B1 (fr) * 1999-12-30 2004-11-26 Gelyma Extrait d'algue a activite filtrante vis a vis des radiations ultraviolettes
ATE420623T1 (de) * 2001-11-14 2009-01-15 Larena Mittel enthaltend ein rote algen extrakt der gattung porphyra und ihre verwendung zum schutz der zellen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024369A1 (en) * 1998-10-23 2000-05-04 Nouvab Inc Solar radiation protection composition
WO2002039974A1 (en) * 2000-11-17 2002-05-23 Natural Environment Research Council Personal care compositions

Also Published As

Publication number Publication date
ES2307438A1 (es) 2008-11-16
ES2303487B1 (es) 2009-05-29
ES2303486B1 (es) 2009-05-29
ES2303488A1 (es) 2008-08-01
WO2007026037A2 (es) 2007-03-08
ES2303488B1 (es) 2009-05-29
ES2303412A1 (es) 2008-08-01
ES2303412B1 (es) 2009-05-29
ES2307438B1 (es) 2009-09-28
ES2303487A1 (es) 2008-08-01
ES2303485A1 (es) 2008-08-01
ES2303486A1 (es) 2008-08-01

Similar Documents

Publication Publication Date Title
Olagunju et al. Pigeon pea enzymatic protein hydrolysates and ultrafiltration peptide fractions as potential sources of antioxidant peptides: An in vitro study
Hayes et al. Boarfish protein recovery using the pH-shift process and generation of protein hydrolysates with ACE-I and antihypertensive bioactivities in spontaneously hypertensive rats
Borah et al. In vitro antioxidant and free radical scavenging activity of Alternanthera sessilis
DE60227838D1 (de) Verfahren zum erhalten neuer formulierungen auf luteinbasis
MX2021014701A (es) Extraccion eutectica de solidos.
WO2009017840A9 (en) Protein and isolated or purified amino acid product containing compositions and uses thereof
WO2008031092A3 (en) Immunostimulatory composition comprising lipoprotein in microalgae extract
WO2007059715A3 (es) Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus
WO2008036932A3 (en) Compositions and methods comprising boswellia species
WO2005016962A3 (en) Compositions and methods for the treatment of immune related diseases
Sompinit et al. In vitro study on novel bioactive peptides with antioxidant and antihypertensive properties from edible rhizomes
CO2022006972A2 (es) Composiciones que comprenden cepas bacterianas para uso en el aumento de la biodisponibilidad de aminoácidos derivados de proteínas
AU2001264515A1 (en) Melphalan derivatives and their use as cancer chemotherapeutic drugs
ES2172442A1 (es) Procedimiento para la produccion de un concentrado de licopeno libre de disolventes organicos, concentrado obtenido y composicion que comprende dicho concentrado.
Alu'datt et al. Antioxidant and antihypertensive properties of phenolic–protein complexes in extracted protein fractions from Nigella damascena and Nigella arvensis
Alu'datt et al. Molecular characterization and bio-functional property determination using SDS-PAGE and RP-HPLC of protein fractions from two Nigella species
JP2011246425A (ja) 大豆蛋白質加水分解物含有抗酸化剤
WO2005082927A3 (en) Antihypertensive peptides
WO2008070350A3 (en) Methods and compositions related to wrapping of dehydrons
DE60221155D1 (de) Negatif geladene polysaccharide aus aloe vera
WO2007026035A3 (es) Aminoácido tipo mcosporina (porphyra 334) como antioxidante
NZ585092A (en) Food material for inhibiting osteoclastogenesis
WO2007026037A3 (es) Mezcla de aminoácidos tipo micosporina (asterine 330 + palitina) como antioxidante
Nagai et al. Functional properties of autolysate and enzymatic hydrolysates from yam tsukuneimo (Dioscorea opposita Thunb.) tuber mucilage tororo: antioxidative activity and antihypertensive activity
WO2007014379A3 (en) A lipidic extract from lepidium meynii and its effect on the libido

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06807936

Country of ref document: EP

Kind code of ref document: A2